DUBLIN, Ireland — Dublin-based Perrigo Company plc has issued a voluntary recall of certain lots of Gerber® Good Start® SootheProTM Powdered Infant Formula that were manufactured at the company’s Gateway Eau Claire, Wisconsin manufacturing facility from January 02, 2023, to January 18, 2023. The recall is being conducted out of an abundance of caution due to the potential presence of Cronobacter sakazakii, although no distributed product has tested positive for the presence of this bacteria, and no adverse events have been reported.
Cronobacter sakazakii is a bacteria commonly found in the environment, which in most people causes no symptoms but in some, particularly premature infants, infants under 2 months of age, or infants with weakened immune systems, fever, poor feeding, excessive crying or low energy, as well as other serious symptoms can occur.
The product is sold at retailers across the United States, and consumers who purchased the product after March 5, 2023, should look for the following lot codes and “use by” dates, which can be found at the bottom of the package. No other lot codes are impacted by this recall. Any consumers who purchased products with matching codes should discontinue use and dispose of the product.
- Gerber® Good Start® SootheProTM 12.4 oz:
- 300357651Z – USE BY 04JUL2024
- 300457651Z – USE BY 05JUL2024
- 300557651Z – USE BY 06JUL2024
- 300557652Z – USE BY 06JUL2024
- 300757651Z – USE BY 08JUL2024
- 300857651Z – USE BY 09JUL2024
- 301057651Z – USE BY 11JUL2024
- 301057652Z – USE BY 11JUL2024
- 301157651Z – USE BY 12JUL2024
- Gerber® Good Start® SootheProTM 30.6 oz:
- 301357652Z – USE BY 14JUL2024
- 301457652Z – USE BY 15JUL2024
- 301557651Z – USE BY 16JUL2024
- Gerber Good® Start® SootheProTM 19.4 oz:
- 301557652Z – USE BY 16JUL2024I
Consumers can request refunds for impacted products and find more information about Gerber® Good Start® by contacting the Gerber Parent Resource Center on behalf of Perrigo at 1-800-777-7690 anytime 24/7. Consumers with any health-related questions should contact their healthcare provider.
This recall is being conducted in consultation with the U.S. Food and Drug Administration (FDA).
